Brain tumors are the 10th leading reason for the death which is common among the adults and children. On the basis of texture, region, and shape there exists various types of tumor, and each one has the chances of survival very low. The wrong classification can lead to the worse consequences. As a result, these had to be properly divided into the many classes or grades, which is where multiclass classification comes into play. Magnetic resonance imaging (MRI) pictures are the most acceptable manner or method for representing the human brain for identifying the various tumors. Recent developments in image classification technology have made great strides, and the most popular and better approach that has been considered best in this area is CNN, and therefore, CNN is used for the brain tumor classification issue in this paper. The proposed model was successfully able to classify the brain image into four different classes, namely, no tumor indicating the given MRI of the brain does not have the tumor, glioma, meningioma, and pituitary tumor. This model produces an accuracy of 99%.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239800PMC
http://dx.doi.org/10.1155/2022/1830010DOI Listing

Publication Analysis

Top Keywords

brain tumor
12
brain
6
tumor
6
cnn based
4
based multiclass
4
multiclass brain
4
tumor detection
4
detection medical
4
medical imaging
4
imaging brain
4

Similar Publications

Background: Supratentorial function-eloquent brain tumour surgeries challenge the balance between maximal tumour resection and preservation of neurological function. This study aims to evaluate the efficacy of preoperative and intraoperative mapping techniques on resection outcomes and post-operative deficits.

Methods: This systematic review and meta-analysis examined literature up to March 2023, sourced from PubMed, Embase, and Medline.

View Article and Find Full Text PDF

Introduction: Glioma is the most common primary malignant brain tumor. Despite advances in surgical techniques and treatment regimens, the therapeutic effects of glioma remain unsatisfactory. Immunotherapy has brought new hope to glioma patients, but its therapeutic outcomes are limited by the immunosuppressive nature of the tumor microenvironment (TME).

View Article and Find Full Text PDF

A recurrent variant c.5126C>T in a Han-Chinese family with tuberous sclerosis complex.

Pak J Med Sci

January 2025

Lamei Yuan, MD, PhD, Health Management Center, the Third Xiangya Hospital, Disease Genome Research Center, Center for Experimental Medicine, the Third Xiangya Hospital, Research Center of Medical Experimental Technology, the Third Xiangya Hospital, Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.

Objective: To identify the disease-causing variant in a family with tuberous sclerosis complex (TSC).

Methods: This study including a Han-Chinese pedigree recruited from the Third Xiangya Hospital, Central South University, Changsha, Hunan, China was conducted between February, 2019 and January, 2023. Detailed clinical examinations were performed on the proband and other family members of a Han-Chinese family with TSC.

View Article and Find Full Text PDF

Mechanisms of Cancer-Induced Bone Pain.

J Pain Res

January 2025

Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.

Bone is a common site of advanced cancer metastasis, second only to the lungs and liver. Cancer-induced bone pain (CIBP) is a persistent and intense pain that is caused by a combination of inflammatory and neuropathic factors. As CIBP progresses, the degree of pain intensifies.

View Article and Find Full Text PDF

Papillary tumors of the pineal region (PTPR) are extremely rare malignancies that make up less than 0.1% of primary brain tumors. They are usually treated with surgery and adjuvant tumor bed radiotherapy (RT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!